These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28135602)

  • 1. Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy.
    Fréour T; Barrière P; Masson D
    Eur J Cancer; 2017 Mar; 74():1-8. PubMed ID: 28135602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer.
    Anderson RA; Su HI
    Front Endocrinol (Lausanne); 2020; 11():574263. PubMed ID: 33117288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study.
    Ünal Ç; Ordu Ç; Özmen T; İlgun AS; Çelebi F; Baysal B; Özkurt E; Duymaz T; Erdoğan İyigün Z; Kurt S; Öztürk MA; Pilancı KN; Alço G; Yararbaş K; Kayan Tapan T; Güven DC; Soybir G; Özmen V
    Curr Oncol; 2023 Oct; 30(10):9217-9229. PubMed ID: 37887566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment.
    Rodgers RJ; Abbott JA; Walters KA; Ledger WL
    Front Endocrinol (Lausanne); 2021; 12():689532. PubMed ID: 34557157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
    Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of vitamin D on ovarian reserve and anti-mullerian hormone in patients undergoing chemotherapy for breast cancer, a randomized phase ΙΙ clinical trial.
    Dastmardi Z; Lashkari M; Saeedian A; Aghili M; Alipour S
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2104. PubMed ID: 38925607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer.
    Ortiz E; Peña CJ; Hidalgo JJ; Monllor-Tormos A; Zolfaroli I; Vila MJ; Sánchez-Serrano M; Pellicer A; Cano A
    J Assist Reprod Genet; 2023 Dec; 40(12):2827-2834. PubMed ID: 37755614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants.
    Oktay KH; Turan V; Bedoschi G; Abdo N; Bang H; Goldfarb S
    Cancer Med; 2023 Sep; 12(18):19225-19233. PubMed ID: 37698031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-Dense Chemotherapy Regimen for Breast Cancer Associated with Significant Decline in Ovarian Reserve.
    Chamani IJ; Gannon A; Connell PT; Bisen A; Kovanci E; Sangi-Haghpeykar H; Woodard T; McKenzie LJ
    J Adolesc Young Adult Oncol; 2024 Jun; 13(3):465-468. PubMed ID: 38112555
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.
    Zhou B; Kwan B; Desai MJ; Nalawade V; Ruddy KJ; Nathan PC; Henk HJ; Murphy JD; Whitcomb BW; Su HI
    Fertil Steril; 2022 May; 117(5):1047-1056. PubMed ID: 35216831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery.
    Wong QHY; Anderson RA
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):391-398. PubMed ID: 30299433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of anti-Müllerian hormone in breast cancer.
    Chen X; Liu S; Peng X; Zong X
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37410375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Bertone-Johnson E; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Liu M; Zeleniuch-Jacquotte A
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4542-e4553. PubMed ID: 34157104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen.
    Tuan Dat D; Huyen Thuong PT; Hong Hai D; Khac Toan N; Tai Duc N; Duy Anh N; Thi Thu Ha N
    Clin Ter; 2024; 175(2):128-134. PubMed ID: 38571471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.
    Yu B; Douglas N; Ferin MJ; Nakhuda GS; Crew K; Lobo RA; Hershman DL
    Cancer; 2010 May; 116(9):2099-105. PubMed ID: 20187091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Model Including AMH Cut-off Levels to Predict Post-treatment Ovarian Function in Early Breast Cancer: A Prospective Cohort Study.
    Omranipour R; Ahmadi-Harchegani F; Saberi A; Moini A; Shiri M; Jalaeefar A; Arian A; Seifollahi A; Madani M; Eslami B; Alipour S
    Arch Iran Med; 2024 Feb; 27(2):96-104. PubMed ID: 38619033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.
    Ge W; Clendenen TV; Afanasyeva Y; Koenig KL; Agnoli C; Brinton LA; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Liu M; Zeleniuch-Jacquotte A
    Int J Cancer; 2018 Jun; 142(11):2215-2226. PubMed ID: 29315564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
    Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy.
    Hoyos-Martinez A; Scheurer ME; Allen-Rhoades W; Okcu MF; Horne VE
    J Adolesc Young Adult Oncol; 2023 Dec; 12(6):828-834. PubMed ID: 36976803
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis.
    Gasparri ML; Di Micco R; Zuber V; Taghavi K; Bianchini G; Bellaminutti S; Meani F; Graffeo R; Candiani M; Mueller MD; Papadia A; Gentilini OD
    Breast; 2021 Dec; 60():155-162. PubMed ID: 34627117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.